**Core Concept:** Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. Receptors play a crucial role in various physiological processes, including neurotransmission, which can be disrupted in schizophrenia.

**Why the Correct Answer is Right:** The correct answer, D, refers to the dopamine D2 receptor, which is the primary target of antipsychotic medications used to treat schizophrenia. Dopamine is a neurotransmitter involved in the regulation of movement, motivation, and reward. In schizophrenia, there is an overactivity of dopaminergic neurotransmission, leading to psychotic symptoms such as delusions, hallucinations, and disorganized thinking. Antipsychotic drugs, including typical and atypical agents, work by blocking dopamine D2 receptors, producing their therapeutic effect.

**Why Each Wrong Option is Incorrect:**

A. Serotonin receptors (5-HT2A) are not the primary target of antipsychotic medications. While some atypical antipsychotics can modulate serotonin neurotransmission, D2 receptors remain the primary target for treating psychotic symptoms.

B. Dopamine D1 receptors are involved in the regulation of movement and are not the primary target of antipsychotic medications.

C. Glutamate NMDA receptors are involved in learning, memory, and synaptic plasticity but are not the primary target of antipsychotic medications.

**Why Schizophrenia is not solely attributable to a single receptor or neurotransmitter:** The disorder's complex nature involves multiple neurotransmitter systems, including dopamine, serotonin, glutamate, and others, interacting with various receptors and neurotransmitter systems. Antipsychotic medications target multiple systems to alleviate the symptoms of schizophrenia.

**Clinical Pearl:** Atypical antipsychotic medications have additional actions beyond blocking dopamine D2 receptors, such as modulating serotonin and glutamate neurotransmission, which contributes to their overall efficacy in treating schizophrenia. However, the primary target remains dopamine D2 receptors. Understanding this concept is crucial for selecting appropriate medications and interpreting treatment outcomes in clinical practice.